Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The aim of this study is to evaluate the effects of heart rate optimization and guided A-V and V-V delay from color Doppler echocardiography, in subjects affected by heart failure with reduced ejection fraction and CRT-D device wearers who did not respond to device implantation in clinical, electrophysiological, and other terms.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Change in the number of acute heart failure episodes | Number of worsening HF episodes requiring hospitalization | Baseline to 12 months post discharge |
| Change in left ventricular ejection fraction (LVEF) | An echocardiogram will be performed at specific study visits and LEVF will be measured | Baseline to 12 months post discharge |
| Echocardiofic changes of diastolic left ventricular function | An echocardiogram will be performed at specific study visits and LVESV and LVEDV will be | Baseline to 12 months post discharge |
| Measure | Description | Time Frame |
|---|---|---|
| Change in Kansas City Cardiomyopathy Questionnaire (KCCQ) | This is a disease-specific health status instrument composed of 23 items that quantify the domains of physical limitation, symptoms, self-efficacy, social limitation, and quality of life limitation due to HF. Scores range from 0 to 100. For the KCCQ overall summary score, a small but clinically meaningful change is ≥ 5 points. | Baseline to 12 months post discharge |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Subjects affected by heart failure with reduced ejection fraction and CRT-D device wearers, who did not respond to the implantation of the device in clinical and electrophysiological terms.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Massimo Saviano, MD | Contact | +390255033579 | massimo.saviano@policlinico.mi.it |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| IRCCS Ospedale Maggiore Policlinico di Milano | Recruiting | Milan | MI | 20122 | Italy |
Not provided
| ID | Term |
|---|---|
| D006333 | Heart Failure |
| ID | Term |
|---|---|
| D006331 | Heart Diseases |
| D002318 | Cardiovascular Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
| Change in NYHA class | Measures of New York Heart Association functional class stratified I to IV at baseline and at each scheduled time. | Baseline to 12 months post discharge |